Pretreatment with Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Inhibitor SF1670 Augments the Efficacy of Granulocyte Transfusion in a Clinically Relevant Mouse Model
View/ Open
44-Yitang-blood-2011.pdf (1.211Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Li, Yitang
Prasad, Amit
Jia, Yonghui
Roy, Saurabh Ghosh
Mondal, Subhanjan
Kocjan, Paulina
Ding, Sheng
Published Version
https://doi.org/10.1182/blood-2010-09-309864Metadata
Show full item recordCitation
Li, Yitang, Amit Prasad, Yonghui Jia, Saurabh Ghosh Roy, Fabien Loison, Subhanjan Mondal, Paulina Kocjan, Leslie E. Silberstein, Sheng Ding, and Hongbo R. Luo. 2011. “Pretreatment with Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Inhibitor SF1670 Augments the Efficacy of Granulocyte Transfusion in a Clinically Relevant Mouse Model.” Blood 117 (24) (April 26): 6702–6713. doi:10.1182/blood-2010-09-309864. http://dx.doi.org/10.1182/blood-2010-09-309864.Abstract
The clinical outcome of granulocyte transfusion therapy is often hampered by short ex vivo shelf life, inefficiency of recruitment to sites of inflammation, and poor pathogen-killing capability of transplanted neutrophils. Here, using a recently developed mouse granulocyte transfusion model, we revealed that the efficacy of granulocyte transfusion can be significantly increased by elevating intracellular phosphatidylinositol (3,4,5)-trisphosphate signaling with a specific phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670. Neutrophils treated with SF1670 were much sensitive to chemoattractant stimulation. Neutrophil functions, such as phagocytosis, oxidative burst, polarization, and chemotaxis, were augmented after SF1670 treatment. The recruitment of SF1670-pretreated transfused neutrophils to the inflamed peritoneal cavity and lungs was significantly elevated. In addition, transfusion with SF1670-treated neutrophils led to augmented bacteria-killing capability (decreased bacterial burden) in neutropenic recipient mice in both peritonitis and bacterial pneumonia. Consequently, this alleviated the severity of and decreased the mortality of neutropenia-related pneumonia. Together, these observations demonstrate that the innate immune responses can be enhanced and the severity of neutropenia-related infection can be alleviated by augmenting phosphatidylinositol (3,4,5)-trisphosphate in transfused neutrophils with PTEN inhibitor SF1670, providing a therapeutic strategy for improving the efficacy of granulocyte transfusion.Other Sources
http://www.ncbi.nlm.nih.gov/pubmed/21521784Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13350262
Collections
- HMS Scholarly Articles [17918]
Contact administrator regarding this item (to report mistakes or request changes)